Vaxcyte 

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range
$29.08-$65
Market Cap
$7.3B
Shares Short
13M

Financials

See more
Revenue (12 Mos)
$0
Revenue Growth (YoY)
0%
Gross Profit (12 Mos)
-$75M
Diluted EPS
-$6.89

News

See more

Yahoo Finance • 10 days ago

How S&P Drug Titan Pfizer Plans To Outdo Its Own $6 Billion Franchise

Yahoo Finance • 11 days ago

What This Fund’s $14 Million Ocular Therapeutix Exit Could Signal for Investors

Yahoo Finance • 2 months ago

Vera Therapeutics Appoints Jane Wright-Mitchell as Chief Legal Officer

Yahoo Finance • 2 months ago

Vaxcyte Completes Enrollment of OPUS-1 and OPUS-2 Phase 3 Trials Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease and Pneumonia in Adults

About

CEO
Mr. Grant E. Pickering M.B.A.
CFO
Mr. Andrew L. Guggenhime M.B.A.
Address
825 Industrial Road, San Carlos, CA, United States, 94070
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
507